The associations between mental health, health-related quality of life and insulin pump therapy among children and adolescents with type 1 diabetes

J Pediatr Endocrinol Metab. 2018 Oct 25;31(10):1065-1072. doi: 10.1515/jpem-2018-0130.

Abstract

Background Diabetes has previously been linked to mental health problems in children and adolescents, but more recent studies have yielded mixed findings. The aim of the current study was to compare symptoms of mental health problems in children and adolescents with and without type 1 diabetes (T1DM). Methods Life quality, subjective well-being, self-rated health, depression and somatic symptoms in children and adolescents with diabetes (n=130) were measured and compared to the results of a socio-demographically joined control group (n=177) which consists of healthy children and adolescents. Results A significant difference could be observed between the groups in well-being and depressive symptoms as according to the results, the research sample namely the children with T1DM could be described with significantly higher subjective well-being and mood, but with less physical symptoms and lower level of depression as those in the control group. Conclusions These findings suggest that T1DM is not associated with an increased risk of psychosocial problems, and confirm that even a severe disease of a child can lead to personal growth.

Keywords: adolescence; glycemic control; health status; health status indicators; insulin pump therapy; mental health; psychological well-being; quality of life; type 1 diabetes.

MeSH terms

  • Adolescent
  • Child
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 1 / psychology*
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / therapeutic use
  • Insulin / administration & dosage
  • Insulin / therapeutic use
  • Insulin Infusion Systems / psychology*
  • Male
  • Mental Health*
  • Quality of Life / psychology*
  • Surveys and Questionnaires
  • Young Adult

Substances

  • Hypoglycemic Agents
  • Insulin